Cargando…

The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial

BACKGROUND: REPRIEVE, the Randomized Trial to Prevent Vascular Events in HIV, is a multicenter, primary prevention trial evaluating whether a statin can prevent major cardiovascular events in people with HIV. REPRIEVE is conducted at >100 clinical research sites (CRSs) globally. Detailed, compreh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulda, Evelynne S., Fichtenbaum, Carl J., Kileel, Emma M., Zanni, Markella V., Aberg, Judith A., Malvestutto, Carlos, Cardoso, Sandra Wagner, Berzins, Baiba, Lira, Rita, Harden, Regina, Robbins, Gregory, Martinez, Maria, Nieves, Sylvia Davila, McCallum, Sara, Cruz, Jorge Leon, Umbleja, Triin, Sprenger, Heather, Giguel, Francoise, Bone, Frederic, Wood, Ken, Byroads, Mark, Paradis, Kayla, Lu, Michael T., Douglas, Pamela S., Ribaudo, Heather J., Grinspoon, Steven K., Fitch, Kathleen V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891172/ https://www.ncbi.nlm.nih.gov/pubmed/36462699 http://dx.doi.org/10.1016/j.cct.2022.107035

Ejemplares similares

Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial
por: Douglas, Pamela S, et al.
Publicado: (2021)

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
por: Kileel, Emma M, et al.
Publicado: (2021)

Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
por: Douglas, Pamela S., et al.
Publicado: (2023)

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV
por: Kolossváry, Márton, et al.
Publicado: (2023)

Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
por: Schnittman, Samuel R., et al.
Publicado: (2023)

Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
por: Zanni, Markella V, et al.
Publicado: (2022)

Reprieve for Perchlorate
por: Renner, R
Publicado: (2002)

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention
por: Hoffmann, Udo, et al.
Publicado: (2021)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Effects of Integrase Inhibitor–Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV
por: Toribio, Mabel, et al.
Publicado: (2020)

No Reprieve: Extreme Heat at Night Contributes to Heat Wave Mortality
por: Seltenrich, Nate
Publicado: (2023)

A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
por: Weiden, Peter J., et al.
Publicado: (2016)

Post-Myocardial Infarction Ventricular Septal Defect: No Reprieve From Doom?
por: Russo, Giulio, et al.
Publicado: (2022)

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
por: Toribio, Mabel, et al.
Publicado: (2018)

A Reprieve from US wildlife mortality on roads during the COVID-19 pandemic
por: Shilling, Fraser, et al.
Publicado: (2021)

Everybody's Page: How to Live to One Hundred.—A Word on Exercise.—A Welcome Reprieve, etc.
Publicado: (1888)

Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV
por: Zanni, Markella V, et al.
Publicado: (2017)

Sextech Use as a Potential Mental Health Reprieve: The Role of Anxiety, Depression, and Loneliness in Seeking Sex Online
por: Marcotte, Alexandra S., et al.
Publicado: (2021)

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus
por: Hall, Leangelo N., et al.
Publicado: (2017)

Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals
por: Mosepele, Mosepele, et al.
Publicado: (2018)

Menopausal Symptoms and Cardiovascular Disease Risk Indices Among Women With HIV
por: Toribio, Mabel, et al.
Publicado: (2021)

Hot Flashes and Cardiovascular Disease Risk Indices Among Women With HIV
por: Toribio, Mabel, et al.
Publicado: (2021)

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1
por: Cespedes, Michelle S., et al.
Publicado: (2018)

Eliciting perspectives of the key study population: An effective strategy to inform advertisement, content and usability of an online survey for a national investigation
por: Kileel, Emma M., et al.
Publicado: (2020)

A Sex-Stratified Analysis of Monocyte Phenotypes Associated with HIV Infection in Uganda
por: Huaman, Moises A., et al.
Publicado: (2021)

Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV
por: Fourman, Lindsay T., et al.
Publicado: (2019)

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
por: Henrich, Timothy J., et al.
Publicado: (2014)

The Association of Distinct Social Determinants of Health with Added Sweetener Knowledge and Consumption in a U.S. Sample of People Living with HIV
por: Kileel, Emma M., et al.
Publicado: (2021)

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review
por: Suero-Abreu, Giselle Alexandra, et al.
Publicado: (2022)

High Intensity Walking Reduces Frailty and Improves Physical Function Among Older Adults Living With HIV
por: Danilovich, Margaret, et al.
Publicado: (2020)

No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial
por: Li, Jonathan Z, et al.
Publicado: (2019)

Similar changes in neuropsychological functioning in english and spanish speaking HIV patients
por: Akpa, Onoja, et al.
Publicado: (2018)

Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
por: Sherman, Kenneth E, et al.
Publicado: (2017)

Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics
por: Li, Jonathan Z., et al.
Publicado: (2014)

Relationship Between Neck Circumference and Cardiometabolic Parameters in HIV-Infected and non–HIV-Infected Adults
por: Fitch, Kathleen V., et al.
Publicado: (2011)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Increased CHIP Prevalence Amongst People Living with HIV
por: Bick, Alexander G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i6scm7992ilo9v09k1nsdm5ne8